Jolanta Bernatoniene, MD, PhD, discusses data showing oral berotralstat significantly reduces moderate and severe attacks in children with hereditary angioedema.
Jolanta Bernatoniene, MD, PhD
Advertisement
Jolanta Bernatoniene, MD, PhD, is a lead investigator at
Bristol Royal Hospital for Children.
Articles by Jolanta Bernatoniene, MD, PhD
Advertisement
Latest Updated Articles
Oral berotralstat shows meaningful reductions in pediatric HAE attacksFebruary 25th 2026
Advertisement
Advertisement
Trending on Contemporary Pediatrics
1
Julie Khlevner, MD, discusses the impact of FDA-approved LINZESS for functional constipation
2
Colleen Cotton, MD, on the importance of early recognition in hidradenitis suppurativa
3
FDA approves ensitrelvir for post-exposure prevention of COVID-19 in adolescents and adults
4
FDA accepts mavacamten (Camzyos) application for adolescent obstructive hypertrophic cardiomyopathy
5